Annual Operating Expenses
$15.77 M
+$3.09 M+24.39%
December 31, 2023
Summary
- As of February 7, 2025, ENTO annual total operating expenses is $15.77 million, with the most recent change of +$3.09 million (+24.39%) on December 31, 2023.
- During the last 3 years, ENTO annual operating expenses has fallen by -$10.66 million (-40.34%).
- ENTO annual operating expenses is now -72.19% below its all-time high of $56.70 million, reached on December 1, 2021.
Performance
ENTO Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Operating Expenses
$1.89 M
-$1.53 M-44.76%
September 1, 2024
Summary
- As of February 7, 2025, ENTO quarterly total operating expenses is $1.89 million, with the most recent change of -$1.53 million (-44.76%) on September 1, 2024.
- Over the past year, ENTO quarterly operating expenses has dropped by -$2.20 million (-53.77%).
- ENTO quarterly operating expenses is now -93.77% below its all-time high of $30.40 million, reached on September 1, 2021.
Performance
ENTO Quarterly Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Operating Expenses Formula
Operating Expenses = Selling, General & Administrative (SG&A) Expenses + Research & Development (R&D) Expenses + Depreciation & Amortization + Other Operating Expenses
ENTO Operating Expenses Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +24.4% | -53.8% |
| 3 y3 years | -40.3% | -53.4% |
| 5 y5 years | +17.4% | -53.6% |
ENTO Operating Expenses Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -72.2% | +24.4% | -79.8% | +143.1% |
| 5 y | 5-year | -72.2% | +24.4% | -93.8% | +143.1% |
| alltime | all time | -72.2% | +233.5% | -93.8% | +143.1% |
Entero Therapeutics Operating Expenses History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $1.89 M(-44.8%) |
| Jun 2024 | - | $3.43 M(-62.9%) |
| Mar 2024 | - | $9.23 M(+125.4%) |
| Dec 2023 | $15.77 M(+24.4%) | $4.09 M(+19.2%) |
| Sep 2023 | - | $3.43 M(-17.9%) |
| Jun 2023 | - | $4.18 M(+2.9%) |
| Mar 2023 | - | $4.06 M(+78.2%) |
| Dec 2022 | $12.68 M(-77.6%) | - |
| Dec 2022 | - | $2.28 M(-151.9%) |
| Sep 2022 | - | -$4.39 M(-181.2%) |
| Jun 2022 | - | $5.41 M(-42.4%) |
| Mar 2022 | - | $9.38 M(+6.4%) |
| Dec 2021 | $56.70 M(+114.5%) | $8.81 M(-71.0%) |
| Sep 2021 | - | $30.40 M(+227.7%) |
| Jun 2021 | - | $9.28 M(+12.9%) |
| Mar 2021 | - | $8.21 M(-52.8%) |
| Dec 2020 | $26.43 M(+79.3%) | $17.40 M(+368.7%) |
| Sep 2020 | - | $3.71 M(+55.1%) |
| Jun 2020 | - | $2.39 M(-18.3%) |
| Mar 2020 | - | $2.93 M(+160.1%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2019 | $14.74 M(+9.8%) | $1.13 M(-72.4%) |
| Sep 2019 | - | $4.08 M(-17.2%) |
| Jun 2019 | - | $4.93 M(+7.1%) |
| Mar 2019 | - | $4.60 M(+14.6%) |
| Dec 2018 | $13.43 M(+31.4%) | $4.02 M(+56.6%) |
| Sep 2018 | - | $2.57 M(-21.4%) |
| Jun 2018 | - | $3.26 M(-9.0%) |
| Mar 2018 | - | $3.58 M(+48.6%) |
| Dec 2017 | $10.22 M(+54.3%) | $2.41 M(-19.0%) |
| Sep 2017 | - | $2.98 M(+40.1%) |
| Jun 2017 | - | $2.12 M(-24.4%) |
| Mar 2017 | - | $2.81 M(+24.0%) |
| Dec 2016 | $6.63 M(+40.1%) | $2.26 M(+75.8%) |
| Sep 2016 | - | $1.29 M(-25.3%) |
| Jun 2016 | - | $1.73 M(+28.0%) |
| Mar 2016 | - | $1.35 M(+265.3%) |
| Dec 2015 | $4.73 M | $368.80 K(-73.8%) |
| Sep 2015 | - | $1.41 M(-25.0%) |
| Jun 2015 | - | $1.88 M(+75.2%) |
| Mar 2015 | - | $1.07 M |
FAQ
- What is Entero Therapeutics annual total operating expenses?
- What is the all time high annual operating expenses for Entero Therapeutics?
- What is Entero Therapeutics annual operating expenses year-on-year change?
- What is Entero Therapeutics quarterly total operating expenses?
- What is the all time high quarterly operating expenses for Entero Therapeutics?
- What is Entero Therapeutics quarterly operating expenses year-on-year change?
What is Entero Therapeutics annual total operating expenses?
The current annual operating expenses of ENTO is $15.77 M
What is the all time high annual operating expenses for Entero Therapeutics?
Entero Therapeutics all-time high annual total operating expenses is $56.70 M
What is Entero Therapeutics annual operating expenses year-on-year change?
Over the past year, ENTO annual total operating expenses has changed by +$3.09 M (+24.39%)
What is Entero Therapeutics quarterly total operating expenses?
The current quarterly operating expenses of ENTO is $1.89 M
What is the all time high quarterly operating expenses for Entero Therapeutics?
Entero Therapeutics all-time high quarterly total operating expenses is $30.40 M
What is Entero Therapeutics quarterly operating expenses year-on-year change?
Over the past year, ENTO quarterly total operating expenses has changed by -$2.20 M (-53.77%)